| Literature DB >> 32513041 |
Lee Revere1, Nina Kavarthapu2, Jessica Hall2, Charles Begley1.
Abstract
The Texas Medicaid Waiver, via the Delivery System Reform Incentive Payment (DSRIP) program, has provided a path for Texas to achieve the Triple Aim through its focus on a defined population at the project and system levels, and financial payment policy based on outcomes. Both iterations of the DSRIP program (Waiver 1.0 and 2.0) have helped define populations, created regional collaboration that sets the stage for a true integrator, and provided financial incentives for improving population health, enhancing patient experience, and controlling costs. The flexible design of project menus and measure bundles in DSRIP encouraged a variety of projects, numerous measures of success and (often) overlapping populations of individual served to achieve the ultimate goal of the Triple Aim. This research outlines the major features of Texas DSRIP and demonstrates the Medicaid Waiver effectively contributed to measurable improvements in health, suggesting Texas safety net providers are moving closer to Triple Aim achievement.Entities:
Keywords: Medicaid Waiver; Triple Aim; outcome assessment; payment reform; population health; safety net providers
Mesh:
Year: 2020 PMID: 32513041 PMCID: PMC7285944 DOI: 10.1177/0046958020923547
Source DB: PubMed Journal: Inquiry ISSN: 0046-9580 Impact factor: 1.730
Relationship Between Triple Aim Preconditions and DSRIP.
| Triple Aim preconditions | Level | DSRIP 1.0 | DSRIP 2.0 |
|---|---|---|---|
| Defined population | State | Statewide MLIU population. | Unchanged. |
| RHP | RHP MLIU population served across | RHP MLIU population served across | |
| Provider | MLIU population served by each | MLIU population served by each | |
| Policy constraints | State | ||
| RHP | Some payments required participation in RHP events/learning collaboration. | Unchanged. | |
| Provider | Participation limited to resource limits and | Participation limited to resource limits and | |
| Existence of an integrator | State | Created infrastructure for statewide reporting and knowledge sharing focused on | Created infrastructure for statewide reporting and knowledge sharing focused on |
| RHP | Created infrastructure for interprovider communication, collaboration, and learning focused on | Created infrastructure for interprovider communication, collaboration, and learning focused on | |
| Provider | Created management structure and processes for | Created management structure and processes for |
Note. DSRIP = Delivery System Reform Incentive Payment; MLIU = Medicaid and low-income uninsured; RHP = Regional Healthcare Partnership.
The underline was to add focus on the key differences between DSRIP 1.0 and 2.0.
DSRIP’s Achievement of the Triple Aim Objectives.
| Triple Aim | Waiver 1.0 | Waiver 2.0 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Health outcomes | Frequency of measure | Baseline denominators: median, range, average | Baseline (DY3) | DY6 | % change (%) | Frequency of measure | Baseline denominators: median, range, average | Baseline (DY6) | DY7 | % change (%) | |
| Population health | Disease Burden | ||||||||||
| Depression remission at 12 months | 11 | 79; 87; 126 | 0.05 | 0.11 | 143 | 16 | 34; 470; 117 | 0.09 | 0.09 | −3 | |
| Latent tuberculosis infection treatment rate | 8 | 281; 589; 305 | 0.56 | 0.78 | 39 | 8 | 172; 926; 282 | 0.45 | 0.33 | −27 | |
| Adults (18+ years) immunization status | 6 | 305; 2377; 665 | 0.34 | 0.40 | 18 | 37 | 9132; 101 078; 20 635 | 0.45 | 0.44 | −3 | |
| Pneumonia vaccination status for older adults | 26 | 640; 26 956; 2012 | 0.56 | 0.81 | 45 | 83 | 1317; 34 401; 2944 | 0.58 | 0.62 | 6 | |
| Influenza immunization | 25 | 854; 20 641; 2322 | 0.21 | 0.50 | 133 | 46 | 8129; 67 837; 13 610 | 0.34 | 0.38 | 12 | |
| Immunization for adolescents—Tdap/TD and MCV | 5 | 228; 3748; 756 | 0.60 | 0.74 | 23 | 18 | 749; 22 622; 2690 | 0.41 | 0.45 | 11 | |
| Behavioral and physiological factors | |||||||||||
| Comprehensive Diabetes Care: HbA1c poor control (>9.0%) | 113 | 317; 30 837; 1942 | 0.36 | 0.31 | 12 | 91 | 793; 43 760; 2929 | 0.33 | 0.30 | 7 | |
| Diabetes care: BP control | 35 | 553; 14 192; 1531 | 0.65 | 0.71 | 10 | 85 | 840; 41 417; 3100 | 0.66 | 0.64 | −3 | |
| Controlling high blood pressure | 75 | 190; 38 828; 1582 | 0.62 | 0.66 | 7 | 52 | 1807; 50 553; 5496 | 0.66 | 0.61 | −7 | |
| Comprehensive Diabetes Care: eye exam | 18 | 8703; 26 342; 13 282 | 0.31 | 0.51 | 64 | 19 | 3007; 13 959; 3105 | 0.36 | 0.42 | 16 | |
| Comprehensive Diabetes Care: foot exam | 37 | 250; 3060; 650 | 0.38 | 0.68 | 78 | 72 | 998; 13 959; 3499 | 0.47 | 0.51 | 8 | |
| Triple Aim | Waiver 1.0 | Waiver 2.0 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Health outcomes | Frequency of measure | Baseline denominators: median, range, average | Baseline (DY3) | DY6 | % change (%) | Frequency of measure | Baseline denominators: median, range, average | Baseline (DY6) | DY7 | % change (%) | |
| Experience | Safe | ||||||||||
| Central line–associated bloodstream infection rates[ | 6 | 49; 31 883; 5347 | 0.01 | 0.00 | 65 | 39 | 9; 130; 18 | 0.87 | 0.65 | 26 | |
| Catheter-associated urinary tract infection rates[ | 8 | 19; 29 253; 3676 | 0.01 | 0.01 | 39 | 39 | 9; 65; 15 | 1.00 | 0.91 | 10 | |
| Surgical site infections rates[ | 6 | 77; 8998; 1574 | 0.01 | 0.00 | 81 | 37 | 11; 65; 28 | 0.77 | 0.70 | 9 | |
| Patient fall rate[ | 11 | 10 144; 143 695; 27 667 | 0.004 | 0.003 | 30 | 39 | 58 942; 65; 83 315 | 2.59 | 2.62 | −1 | |
| Effective | |||||||||||
| Preventative care and screening: screening for high blood pressure and follow-up documented | 16 | 335; 14 375; 1523 | 0.44 | 0.74 | 67 | 47 | 4198; 344 032; 6939 | 0.45 | 0.53 | 18 | |
| Body mass index screening and follow-up | 26 | 432; 20 248; 1776 | 0.62 | 0.90 | 45 | 64 | 6924; 151 691; 18 949 | 0.48 | 0.66 | 38 | |
| Tobacco use: screening and cessation intervention | 10 | 886; 13 495; 3485 | 0.54 | 0.61 | 13 | 122 | 3920; 139 993; 10 457 | 0.75 | 0.82 | 10 | |
| Follow-up after hospitalization for mental illness | 33 | 98; 2622; 442 | 0.24 | 0.52 | 116 | 31 | 201; 85 953; 576 | 0.35 | 0.61 | 75 | |
| Chlamydia screening in women | 9 | 107; 1405; 355 | 0.28 | 0.86 | 212 | 33 | 509; 9351; 1082 | 0.54 | 0.55 | 1 | |
| Breast cancer screening | 29 | 681; 28 437; 2853 | 0.51 | 0.62 | 21 | 38 | 2458; 43 042; 6885 | 0.67 | 0.70 | 5 | |
| Cervical cancer screening | 23 | 813; 15 408; 2259 | 0.49 | 0.56 | 16 | 35 | 6313; 99 390; 13 811 | 0.52 | 0.64 | 23 | |
| Colorectal cancer screening | 30 | 489; 37 692; 3832 | 0.48 | 0.60 | 26 | 38 | 4290; 73 353; 12 944 | 0.48 | 1.09 | 11 | |
| Timely | |||||||||||
| Third next available appointment[ | 20 | 3; 12; 4 | 46.65 | 10.56 | 77 | 1 | 1; 1; 1 | 12.00 | 11.60 | 3 | |
| Patient centered | |||||||||||
| Hospice and palliative care—treatment preferences | 15 | 112; 1049; 241 | 0.42 | 0.70 | 67 | 16 | 508; 2726; 767 | 0.62 | 0.53 | −15 | |
| Beliefs and values—percentage of hospice patients with documentation in the clinical record of a discussion of spiritual/religious concerns or documentation that the patient/caregiver did not want to discuss. | 18 | 137; 301; 185 | 0.49 | 0.86 | 74 | 16 | 291; 2792; 649 | 0.65 | 0.68 | 4 | |
Measured as actual observed events over calculated expected events.
Measured as falls per patient days.
Continuous measure with a denominator including number of providers in DSRIP 1.0 and denominator of 1 in 2.0. The measure looks at the average number of days to next available appointment.
| Triple Aim | Waiver 1.0 | Waiver 2.0 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Health outcomes | Frequency of measure | Baseline denominators: median, range, average | Baseline (DY3) | DY6 | % change (%) | Frequency of measure | Baseline denominators: median, range, average | Baseline (DY6) | DY7 | % change (%) | |
| Cost | Per capita cost | ||||||||||
| None | |||||||||||
| Utilization | |||||||||||
| Risk-adjusted CHF 30-day readmission rate[ | 51 | — | 1.07 | 0.88 | 18 | 3 | — | 1.37 | 1.25 | 9 | |
| Risk-adjusted all-cause readmission[ | 56 | — | 1.01 | 0.78 | 23 | 22 | — | 0.96 | 0.96 | 1 | |
| Reduce emergency department visits for behavioral health and substance abuse | 25 | 10 968; 93 296; 23 240 | 0.08 | 0.08 | 7 | 8 | 44 579; 220 711; 66 589 | 0.09 | 0.14 | −63 | |
| Risk-adjusted behavioral health/substance abuse 30-day readmission rate[ | 13 | — | 1.02 | 0.82 | 20 | 5 | — | 0.80 | 0.88 | −9 | |
| Reduce mental health admissions and readmissions to criminal justice settings | 35 | 74.5; 4144; 439.43 | 0.20 | 0.17 | −12 | 5 | 2886; 8526; 3239 | 0.08 | 0.10 | −14 | |
| Reduce rate of emergency department visits for diabetes | 23 | 17 274; 164 960; 28 750 | 0.09 | 0.10 | −7 | 74 | 2915; 74 342; 7778 | 0.25 | 0.29 | −16 | |
Note. DSRIPs = Delivery System Reform Incentive Payment; CHF = congestive heart failure; BP = blood pressure.
Measure’s denominator and numerator are rates. Baselines and DY6 were averaged.